Butabarbital and olopatadine intranasal each boost sedation. Keep away from or Use Alternate Drug. Coadministration boosts possibility of CNS depression, which may lead to additive impairment of psychomotor general performance and lead to daytime impairment. butabarbital will reduce the extent or influence of midazolam by impacting hepatic/intestinal enzyme CYP3A4 metabolism. https://juniush887ahn5.blog-eye.com/profile